Medinotec Inc. (MDNC): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2025-02-28 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$4.60M

Year ended 2026-02-28

2023-02-28 Cost of Revenue (USD) 2026-02-28

Period ended	Cost of Revenue	Change YoY	Source filing
2026-02-28	$4.60M	+7.1%	2026-05-28, From 2025-03-01
2025-02-28	$4.30M	n/c	2026-05-28, From 2024-03-01
2024-02-29	-$2.58M	n/m	2025-05-29, From 2023-03-01
2023-02-28	-$417.8K	n/a	2024-07-05, From 2022-03-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cost of Revenue	Change YoY
Medinotec Inc. (MDNC)	2026-02-28	$4.60M	+7.1%
Neuroone Medical Technologies Corp (NMTC)	2025-09-30	$3.96M	+66.7%
InspireMD, Inc. (NSPR)	2025-12-31	$6.33M	+15.0%
Nexgel, Inc. (NXGL)	2025-12-31	$6.91M	+16.4%
Beyond Air, Inc. (XAIR)	2026-03-31	$7.43M	+38.4%
INVO Fertility, Inc. (IVF)	2025-12-31	$30.6K	+150.6%
Encision Inc (ECIA)	2025-03-31	$3.04M	-11.8%
Allurion Technologies, Inc. (ALUR)	2025-12-31	$5.66M	-46.6%
Biotricity Inc. (BTCY)	2026-03-31	$3.05M	-5.5%

Compare MDNC, NMTC, NSPR, NXGL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗